Brent L. Larson
2016
In 2016, Brent L. Larson earned a total compensation of $194.2K as Executive Vice President and Chief Financial Officer at Navidea Biopharmaceuticals, a 58% decrease compared to previous year.
Compensation breakdown
| Salary | $188,393 |
|---|---|
| Other | $5,826 |
| Total | $194,219 |
Larson received $188.4K in salary, accounting for 97% of the total pay in 2016.
Larson also received $5.8K in other compensation.
Rankings
In 2016, Brent L. Larson's compensation ranked 13,437th out of 14,075 executives tracked by ExecPay. In other words, Larson earned more than 4.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,437 out of 14,075 | 5th |
Division Manufacturing | 5,247 out of 5,486 | 4th |
Major group Chemicals And Allied Products | 1,838 out of 1,900 | 3rd |
Industry group Drugs | 1,491 out of 1,543 | 3rd |
Industry In Vitro and In Vivo Diagnostic Substances | 61 out of 65 | 6th |
Source: SEC filing on May 24, 2017.
Larson's colleagues
We found six more compensation records of executives who worked with Brent L. Larson at Navidea Biopharmaceuticals in 2016.
2016
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2016
Jed Latkin
Navidea Biopharmaceuticals
Chief Financial Officer
2016
Thomas Klima
Navidea Biopharmaceuticals
Senior Vice President and Chief Commercial Officer
2016
William Regan
Navidea Biopharmaceuticals
Senior Vice President and Chief Compliance Officer
2016
Michael Goldberg
Navidea Biopharmaceuticals
Chief Executive Officer
2016
Ricardo Gonzalez
Navidea Biopharmaceuticals